This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Rangarao Kajipalya: Innovator in Mycobacterial Treatment
Introduction
Rangarao Kajipalya is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of medical science, particularly in the treatment of mycobacterial diseases. His innovative approach has led to the development of a unique patent that addresses critical health challenges.
Latest Patents
Rangarao holds a patent for "Mycobacterial inhibitors." This invention provides the use of certain succinimide compounds in the treatment of mycobacterial diseases. His work in this area is crucial for advancing therapeutic options for patients suffering from these conditions.
Career Highlights
Rangarao is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
Rangarao has worked alongside talented colleagues such as Meenakshi Balganesh and Kantharaj Ethirajulu. Their combined expertise fosters an environment of innovation and progress in their respective fields.
Conclusion
Rangarao Kajipalya's contributions to the treatment of mycobacterial diseases through his patent demonstrate his commitment to improving healthcare. His work at AstraZeneca AB and collaborations with fellow researchers highlight the importance of teamwork in driving innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile